ALX Oncology
Selina Lau is a highly experienced finance professional currently serving as the Director of Corporate Accounting and Financial Reporting at ALX Oncology since June 2021, where responsibilities include managing SEC filings, equity stock administration, and audit support. Previously, Selina held positions such as Senior Manager of SEC Reporting and Accounting Manager at ALX Oncology, Senior Accountant at Tizona Therapeutics, and Assurance Senior at EY. Early career roles include AP & Billing Coordinator at Bonhams and Accounting Clerk at UCLA Pediatrics Department. Selina holds a Bachelor’s Degree in Psychobiology from UCLA and a Certificate of Advanced Accounting Proficiency from Santa Clara University.
This person is not in any teams
ALX Oncology
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.